AFL stock forecast, quote, news & analysis

Key Takeaways

• Aflac (AFL) shares climbed roughly +10.8% over the last 30 days, rising from $111.78 to $123.89.
• The advance reversed a multi-week slide that had carried the stock from a late-July peak near $129 to an early-October low around $110.
• The rebound unfolded even as several analysts trimmed price targets and set expectations for a year-over-year decline in upcoming quarterly results.
• Aflac's franchise spans Japan (about 53% of sales) and the U.S. (about 39%), backed by a decades-long record of dividend increases.
• Key watch items include the November 4 earnings report, yen/dollar exchange-rate swings, and premium trends in Japan and the U.S.
• For additional detail, explore Aflac's Price Targets, Earnings, and Forecast pages.
• Interested in automated strategies? Explore Trending AI Robots to see how AI-driven bots are trading the market.

Aflac (AFL) Company Overview and Market Position

Aflac Incorporated is a supplemental health and life insurance provider best known for its Aflac duck brand. The company operates two primary segments: Aflac Japan, which contributes the majority of revenue, and Aflac U.S. Its products include cancer, medical, accident, disability, dental, and vision plans, sold largely through workplaces and direct distribution channels.

Investors follow Aflac for its defensive, cash-generative business model, its long history of shareholder returns, and its exposure to Japan's aging population. The company has raised its dividend for more than four decades, a track record that reinforces its appeal as a dividend-oriented holding even as foreign-exchange moves and slower premium growth weigh on reported results.

Aflac (AFL) Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, Aflac shares advanced roughly +10.8%, moving from a close of $111.78 to $123.89. The stock found a bottom near $110 in early October before staging a steady recovery through the rest of the month.

The broader quarterly picture is more mixed. Over the last three months, the stock was down about -2.8%, reflecting a pronounced V-shaped pattern. After peaking near $129 in late July, shares declined through August and September, bottoming around $110 in early October, and then recovered strongly. The recent 30-day rally therefore represents a rebound from a meaningful pullback rather than an uninterrupted uptrend.

What Drove AFL Stock Price in the Last 30 Days

The stock's October advance was driven less by a single catalyst than by a combination of sector rotation, valuation support, and improving risk appetite. After the late-summer decline pushed Aflac into the low $110s, buyers returned to a defensive, dividend-paying insurer offering a relatively attractive valuation.

Analyst activity was mixed during the period. Wells Fargo maintained a Hold rating with a $116 price target, while Piper Sandler reiterated a Buy rating. BofA kept its Buy rating but lowered its price target to $133 from $137, and Keefe, Bruyette & Woods adjusted its target to $120 from $125. These revisions, while varied, signaled that much of the short-term downside had already been priced in ahead of the stock's recovery.

What Drove AFL Stock Performance Over the Last Quarter

The quarterly decline and subsequent recovery reflect broader pressures on Aflac's earnings outlook. In its second-quarter results, reported in early August, the company posted adjusted earnings per share of $1.75, below the consensus estimate of $1.78, though revenue of $4.12 billion was roughly in line with expectations. A weaker yen remained a headwind for the Japan segment.

Looking ahead, analysts expect the upcoming quarter to show a year-over-year decline, with consensus estimates around $1.80 per share and approximately $4.2 billion in revenue, both below the prior-year period. This softer outlook, combined with yen volatility and premium pressure in Japan and the U.S., contributed to the choppy multi-month trading range before the recent recovery.

Trending AI Robots

For traders who prefer a systematic approach, Tickeron's Trending AI Robots page highlights a curated selection of automated trading strategies. Tickeron offers hundreds of AI trading bots that trade thousands of tickers, but only the top-performing and most relevant bots appear in this featured section. The bots vary by strategy, timeframe, and performance metrics, allowing users to compare approaches across different market conditions. Reviewing these tools can provide additional perspective on how data-driven systems are navigating names like Aflac and the broader insurance sector.

AFL Stock Forecast Drivers: What Investors Should Watch Next

The most important near-term event is Aflac's next earnings report, expected around November 4. Investors will focus on whether adjusted earnings and revenue meet consensus, how Japan's premium trends and benefit ratios evolve, and whether yen weakness continues to pressure translated results. Management's commentary on U.S. premium growth, product initiatives, and capital-return plans will also be closely watched.

Beyond earnings, key factors include interest-rate and currency movements, regulatory developments in the supplemental insurance market, and the pace of share buybacks and dividend increases. These elements will shape whether the stock's recent rebound can be sustained.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations